4097 related articles for article (PubMed ID: 9447442)
1. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging.
Jobst KA; Barnetson LP; Shepstone BJ
Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442
[TBL] [Abstract][Full Text] [Related]
2. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and Apo E4 in medial temporal lobe dementias. Oxford Project to Investigate Memory and Aging.
Jobst KA; Barnetson LP; Shepstone BJ
Int Psychogeriatr; 1998 Sep; 10(3):271-302. PubMed ID: 9785148
[TBL] [Abstract][Full Text] [Related]
3. The diagnosis of Alzheimer's disease: a question of image?
Jobst KA; Hindley NJ; King E; Smith AD
J Clin Psychiatry; 1994 Nov; 55 Suppl():22-31. PubMed ID: 7989291
[TBL] [Abstract][Full Text] [Related]
4. Association between medial temporal lobe atrophy on CT and parietotemporal uptake decrease on SPECT in Alzheimer's disease.
Lavenu I; Pasquier F; Lebert F; Jacob B; Petit H
J Neurol Neurosurg Psychiatry; 1997 Oct; 63(4):441-5. PubMed ID: 9343120
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity, specificity, and positive predictive value of technetium 99-HMPAO SPECT in discriminating Alzheimer's disease from other dementias.
Masterman DL; Mendez MF; Fairbanks LA; Cummings JL
J Geriatr Psychiatry Neurol; 1997 Jan; 10(1):15-21. PubMed ID: 9100154
[TBL] [Abstract][Full Text] [Related]
6. The validity and reliability of 6 sets of clinical criteria to classify Alzheimer's disease and vascular dementia in cases confirmed post-mortem: added value of a decision tree approach.
Hogervorst E; Bandelow S; Combrinck M; Irani SR; Smith AD
Dement Geriatr Cogn Disord; 2003; 16(3):170-80. PubMed ID: 12826744
[TBL] [Abstract][Full Text] [Related]
7. SPECT in Alzheimer's disease: features associated with bilateral parietotemporal hypoperfusion.
Nitrini R; Buchpiguel CA; Caramelli P; Bahia VS; Mathias SC; Nascimento CM; Degenszajn J; Caixeta L
Acta Neurol Scand; 2000 Mar; 101(3):172-6. PubMed ID: 10705939
[TBL] [Abstract][Full Text] [Related]
8. [Neuroimaging in the diagnosis of Alzheimer's disease].
Hanyu H; Nakano S; Abe S; Arai H; Iwamoto T; Takasaki M
Nihon Ronen Igakkai Zasshi; 1994 Sep; 31(9):683-9. PubMed ID: 7823403
[TBL] [Abstract][Full Text] [Related]
9. Regional HmPAO SPECT and CT measurements in the diagnosis of Alzheimer's disease.
Mattman A; Feldman H; Forster B; Li D; Szasz I; Beattie BL; Schulzer M
Can J Neurol Sci; 1997 Feb; 24(1):22-8. PubMed ID: 9043743
[TBL] [Abstract][Full Text] [Related]
10. Correlation of rCBF (SPECT), CSF tau, and cognitive function in patients with dementia of the Alzheimer's type, other types of dementia, and control subjects.
Tsolaki M; Sakka V; Gerasimou G; Dimacopoulos N; Chatzizisi O; Fountoulakis KN; Kyriazis G; Papanastasiou J; Kazis A
Am J Alzheimers Dis Other Demen; 2001; 16(1):21-31. PubMed ID: 11416945
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the diagnostic sensitivity of MRI, CBF-SPECT, FDG-PET and cerebrospinal fluid biomarkers for detecting Alzheimer's disease in a memory clinic.
Morinaga A; Ono K; Ikeda T; Ikeda Y; Shima K; Noguchi-Shinohara M; Samuraki M; Yanase D; Yoshita M; Iwasa K; Mastunari I; Yamada M
Dement Geriatr Cogn Disord; 2010; 30(4):285-92. PubMed ID: 20861634
[TBL] [Abstract][Full Text] [Related]
12. [Molecular neuroimaging in the study of cognitive impairment: contribution of the cerebral blood flow SPECT with 99mTc-HMPAO and 18F-FDG PET/CT scan].
Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla J; Portilla-Quattrociocchi H; Medina-Quiroz P; Ortega F; Rodríguez E; Mateo I; Vázquez-Higuera JL; de Arcocha M; Carril JM
Rev Esp Med Nucl; 2011; 30(5):301-6. PubMed ID: 21640440
[TBL] [Abstract][Full Text] [Related]
13. Medial temporal lobe atrophy, apolipoprotein genotype, and plasma homocysteine in Sri Lankan patients with Alzheimer's disease.
de Silva HA; Gunatilake SB; Johnston C; Warden D; Smith AD
Exp Aging Res; 2005; 31(3):345-54. PubMed ID: 16036726
[TBL] [Abstract][Full Text] [Related]
14. Increasing the diagnostic accuracy of medial temporal lobe atrophy in Alzheimer's disease.
Jacobs HI; Van Boxtel MP; van der Elst W; Burgmans S; Smeets F; Gronenschild EH; Verhey FR; Uylings HB; Jolles J
J Alzheimers Dis; 2011; 25(3):477-90. PubMed ID: 21471642
[TBL] [Abstract][Full Text] [Related]
15. Combined magnetic resonance imaging and single-photon emission tomography scanning in the discrimination of Alzheimer's disease from age-matched controls.
O'Brien JT; Ames D; Desmond P; Lichtenstein M; Binns D; Schweitzer I; Davis S; Tress B
Int Psychogeriatr; 2001 Jun; 13(2):149-61. PubMed ID: 11495391
[TBL] [Abstract][Full Text] [Related]
16. Functional brain imaging with single-photon emission computed tomography in the diagnosis of Alzheimer's disease.
Waldemar G; Høgh P; Paulson OB
Int Psychogeriatr; 1997; 9 Suppl 1():223-7; discussion 247-52. PubMed ID: 9447443
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimer's disease and frontotemporal dementia.
Varma AR; Snowden JS; Lloyd JJ; Talbot PR; Mann DM; Neary D
J Neurol Neurosurg Psychiatry; 1999 Feb; 66(2):184-8. PubMed ID: 10071097
[TBL] [Abstract][Full Text] [Related]
18. Accuracy of single-photon emission computed tomography in differentiating frontotemporal dementia from Alzheimer's disease.
McNeill R; Sare GM; Manoharan M; Testa HJ; Mann DM; Neary D; Snowden JS; Varma AR
J Neurol Neurosurg Psychiatry; 2007 Apr; 78(4):350-5. PubMed ID: 17158559
[TBL] [Abstract][Full Text] [Related]
19. Semi-quantitative analysis of perfusion of Brodmann areas in the differential diagnosis of cognitive impairment in Alzheimer's disease, fronto-temporal dementia and mild cognitive impairment.
Tranfaglia C; Palumbo B; Siepi D; Sinzinger H; Parnetti L
Hell J Nucl Med; 2009; 12(2):110-4. PubMed ID: 19675861
[TBL] [Abstract][Full Text] [Related]
20. Parametric mapping of cerebral blood flow deficits in Alzheimer's disease: a SPECT study using HMPAO and image standardization technique.
Imran MB; Kawashima R; Awata S; Sato K; Kinomura S; Ono S; Yoshioka S; Sato M; Fukuda H
J Nucl Med; 1999 Feb; 40(2):244-9. PubMed ID: 10025830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
